Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
48,113,379
-
Total 13F shares
-
45,557,409
-
Share change
-
+11,125,430
-
Total reported value
-
$875,822,951
-
Put/Call ratio
-
552%
-
Price per share
-
$19.23
-
Number of holders
-
103
-
Value change
-
+$220,884,500
-
Number of buys
-
60
-
Number of sells
-
30
Institutional Holders of Oruka Therapeutics, Inc. - Common Stock (ORKA) as of Q3 2025
As of 30 Sep 2025,
Oruka Therapeutics, Inc. - Common Stock (ORKA) was held by
103 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
45,557,409 shares.
The largest 10 holders included
FMR LLC, VR ADVISER, LLC, Fairmount Funds Management LLC, VIKING GLOBAL INVESTORS LP, Deep Track Capital, LP, BlackRock, Inc., RTW INVESTMENTS, LP, VANGUARD GROUP INC, Commodore Capital LP, and BRAIDWELL LP.
This page lists
103
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.